文献速递关节外科

保留血液的全关节置换术后是否应常规检查血红蛋白和钾水平?

Should postoperative haemoglobin and potassium levels be checked routinely following blood-conserving primary total joint arthroplasty?
PubMed 文献 · Bone Joint J · 2019-01-01

研究回顾性分析2016年7月至2017年2月单中心1132例初次全髋或全膝关节置换术患者,均采用统一围手术期血液保护方案。总体输血率1.06%,15.5%患者需补钾;作者建议术前血红蛋白低于130 g/dl或钾低于4 mmol/l且合并内科共病者才术后常规查血常规和基础代谢面板。

要点

  • 1132例全关节置换术中输血率1.06%,需输血者术前血红蛋白均低于130 g/l。
  • 15.5%患者需补钾,其中72%术前钾低于4 mmol/l,余28%有贫血或心肺肾疾病史。
  • 作者建议术前血红蛋白低于130 g/dl或钾低于4 mmol/l且有合并症者才术后常规查血常规和基础代谢面板。

核心结论

  • 一致的围手术期血液保护策略使全关节置换术患者输血需求低于既往文献报告率。
  • 作者建议术前血红蛋白低于130 g/dl或钾低于4 mmol/l且有内科共病者才术后常规查全血细胞计数和基础代谢面板。

研究设计与样本

  • 回顾性研究,纳入2016年7月至2017年2月单中心初次全髋或全膝关节置换术患者。
  • 研究人群为1023例患者共1132例全关节置换术,所有患者实施统一血液保护方案。
  • 输血或补钾需求由医疗团队协调决定。

主要发现

  • 总体输血率为1.06%(12/1132),12例需输血者中11例为女性,10例为全髋关节置换术,全部12例术前血红蛋白低于130 g/l。
  • 需输血患者的手术时长和手术失血量显著大于无需输血者。
  • 几乎所有需输血患者有心血管疾病史或危险因素。
  • 15.5%的研究队列需要补钾;其中72%术前检查钾低于4 mmol/l,其余28%有需大量医疗管理的显著贫血、心肺、心血管或肾脏疾病史。

临床怎么用

  • 作者建议术后全血细胞计数和基础代谢面板不应常规开具,除非患者术前血红蛋白低于130 g/dl或钾低于4 mmol/l且合并内科共病。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Despite declining frequency of blood transfusion and electrolyte supplementation following total joint arthroplasty, postoperative blood analyses are still routinely ordered for these patients. This study aimed to determine the rate of blood transfusion and electrolyte restoration in arthroplasty patients treated with a perioperative blood conservation protocol and to identify risk factors that would predict the need for transfusion and electrolyte supplementation. PATIENTS AND METHODS: Patients undergoing primary total joint arthroplasty of the hip or knee between July 2016 and February 2017 at a single institution were included in the study. Standard preoperative and postoperative laboratory data were collected and reviewed retrospectively. A uniform blood conservation programme was implemented for all patients. Need for blood transfusion or potassium supplementation was determined through a coordinated decision by the care team. Rates of transfusion and supplementation were observed, and patient risk factors were noted. RESULTS: The overall rate of blood transfusion was 1.06% in the study population of 1132 total joint arthroplasties performed in 1023 patients. Of the 12 patients requiring transfusion, 11 were female, ten occurred in patients undergoing total hip arthroplasty, and all 12 patients had a preoperative haemoglobin level less than 130 g/l. Operative duration and surgical blood loss were significantly greater in those patients requiring blood transfusion. Nearly all patients requiring transfusion had a history of, or risk factors for, cardiovascular disease. Potassium supplementation was required in 15.5% of the study cohort; 72% of these patients receiving potassium presented with a potassium level less than 4 mmol/l during preoperative testing, while the remaining 28% had a past medical history of either significant anaemia, cardiopulmonary, cardiovascular, or renal diseases that had required substantial medical management. CONCLUSION: A consistent blood-conserving perioperative strategy effectively minimized need for blood transfusion in total joint arthroplasty patients below previously reported rates in the literature. We suggest that postoperative full blood counts and basic metabolic panels should not routinely be ordered in these patients unless their preoperative haemoglobin and potassium is below 130 g/dl or 4 mmol/l respectively, and they have medical comorbidities.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Greco NJ, Manocchio AG, Lombardi AV, et al. Should postoperative haemoglobin and potassium levels be checked routinely following blood-conserving primary total joint arthroplasty? Bone Joint J. 2019. PMID: 30648494. doi:10.1302/0301-620X.101B1.BJJ-2018-0554.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。